VSTM (STOCKS)
Verastem, Inc.
$5.660000
+0.350000 (+6.59%)
Prev close: $5.310000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Daniel W. Paterson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $495.83M
- Employees
- 78
- P/E (TTM)
- -1.70
- P/B (TTM)
- 7.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $30.91M |
| Benefits Costs and Expenses | $240.39M |
| Costs And Expenses | $201.04M |
| Operating Expenses | $201.04M |
| Selling, General, and Administrative Expenses | $81.15M |
| Research and Development | $114.60M |
| Other Operating Expenses | $5.30M |
| Operating Income/Loss | -$170.13M |
| Income/Loss From Continuing Operations After Tax | -$209.47M |
| Income/Loss From Continuing Operations Before Tax | -$209.47M |
| Interest Expense, Operating | $1.14M |
| Net Income/Loss | -$209.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$209.47M |
| Net Income/Loss Available To Common Stockholders, Basic | -$209.47M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.02 |
| Diluted Earnings Per Share | -$3.02 |
| Basic Average Shares | 69,309,000 |
| Diluted Average Shares | 69,309,000 |
| Assets | $246.44M |
| Current Assets | $223.41M |
| Cash | $205.00M |
| Inventory | $1.83M |
| Other Current Assets | $16.58M |
| Noncurrent Assets | $23.03M |
| Liabilities | $189.25M |
| Current Liabilities | $72.27M |
| Accounts Payable | $12.45M |
| Wages | $10.86M |
| Other Current Liabilities | $48.96M |
| Noncurrent Liabilities | $116.98M |
| Equity | $57.20M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $57.20M |
| Liabilities And Equity | $246.44M |
| Net Cash Flow From Operating Activities | -$137.51M |
| Net Cash Flow From Operating Activities, Continuing | -$137.51M |
| Net Cash Flow From Investing Activities | -$9.62M |
| Net Cash Flow From Investing Activities, Continuing | -$9.62M |
| Net Cash Flow From Financing Activities | $263.31M |
| Net Cash Flow From Financing Activities, Continuing | $263.31M |
| Net Cash Flow | $116.17M |
| Net Cash Flow, Continuing | $116.17M |
| Comprehensive Income/Loss | -$204.24M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$204.24M |
| Other Comprehensive Income/Loss | $5.23M |